Technological advances that could improve diabetes control in the future made the news in the past month.
World Diabetes Day is to be held on Nov. 14 and President Obama recently proclaimed November to be National Diabetes Month.
Two recent studies and FDA approval of the first “artificial pancreas” highlight new technological advances in type 1 diabetes care.
The prevalence and treatment of diabetes complications affecting the eye were analyzed by multiple studies published in the past month.
Two recent studies analyzed the effects of exercise on glycemic control in patients with type 2 diabetes or impaired glucose tolerance.
Three studies published in December looked at hypoglycemia, focusing on rates of severe hypoglycemia in the U.S., patients at high risk for hypoglycemia, and potential use of intranasal glucagon to treat the condition.
The effects of lifestyle interventions on patients with diabetes were analyzed by several recent studies.
The American Association of Clinical Endocrinologists and the American College of Endocrinology updated their algorithm for treatment of type 2 diabetes, while the American Diabetes Association released a position statement on management of diabetes
Renal side effects of diabetes drugs were in the news in the past month, with one industry-funded study finding an association between empagliflozin and slower progression of kidney disease and the FDA strengthening an existing warning on risk of
The risks of cancer in patients taking medication for diabetes were analyzed by 2 recent studies.